MoonLake Immunotherapeutics (MLTX) Net Income towards Common Stockholders Growth (1y) (2022 - 2026)
MoonLake Immunotherapeutics (MLTX) Net Income towards Common Stockholders Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -88.68% |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -58.11% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 104.24% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -290.15% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -129.68% |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -230.18% |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 59.59% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | MoonLake Immunotherapeutics | 1.25 Bn | 888.66 Mn | - | -71.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -71.87% |
| Dec 31, 2025 | -35.83% |
| Sep 30, 2025 | -95.75% |
| Jun 30, 2025 | -126.39% |
| Mar 31, 2025 | -190.23% |
| Dec 31, 2024 | -488.23% |
| Sep 30, 2024 | -210.81% |
| Jun 30, 2024 | -100.42% |
| Mar 31, 2024 | -14.37% |
| Dec 31, 2023 | 52.11% |
| Sep 30, 2023 | 21.18% |
| Jun 30, 2023 | 29.07% |
| Mar 31, 2023 | 23.05% |
| Dec 31, 2022 | 69.30% |
| Sep 30, 2022 | -134.44% |
| Jun 30, 2022 | 46.72% |
| Mar 31, 2022 | -20,715.22% |